AI assistant
Dare Bioscience, Inc. — Director's Dealing 2015
Nov 30, 2015
34825_dirs_2015-11-30_0b6c3a30-c367-4f0c-9de9-20ddd60e1fdf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-11-25
Reporting Person: WALT DAVID R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-25 | Common Stock | P | 5417 | $3.3659 | Acquired | 5417 | Direct |
| 2015-11-27 | Common Stock | P | 6700 | $3.2782 | Acquired | 12117 | Direct |
Footnotes
F1: Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $3.35 to $3.41 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
F2: Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $3.25 to $3.32 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.